BioSpace News Archive

Employees who have found depression relief with NeuroStar Advanced Therapy for Mental Health use their voice to help others

Vaxart to advance three oral tablet COVID-19 vaccine candidates to the clinic: VXA-CoV2-1 (includes both the S and the N proteins) into Phase II and two S-only constructs into Phase I/II Four clinical trials of the oral norovirus vaccine candidate to be initiated in 2021 Cash, cash equivalents, and marketable securities of $177.3 million as of March 31, 2021

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it will release first quarter 2021 financial results after market close on Monday, May 10, 2021.

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark of the Evolut™ PRO+ TAVI System – the newest-generation Medtronic TAVI system that builds off the proven self-expanding, supra-annular Evolut TAVI platform

MIMEDX Group, Inc., an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with its 2021 Annual Meeting of Shareholders, to be held virtually on May 27, 2021 at 10:00 a.m. Eastern Time at www.cesonlineservices.com/mdxg21_vm.

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical.

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ORTHO VISION® Swift and ORTHO VISION® Max Swift Analyzers.

FARE, the world’s leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, is excited to announce programming and details around its annual Living TealTM Food Allergy Awareness Week.

Esteve Pharmaceuticals (ESTEVE), an international specialty pharmaceutical company devoted to the development and commercialization of innovative products, today announced an agreement with Kowa Pharmaceuticals America, Inc.

May is National Mental Health Awareness Month and The National Kidney Foundation recognizes this important month by calling attention to NKF Peers, a free mentoring program that matches people in late stage kidney disease, those on dialysis or living with a transplant, as well as living donors with mentors who provide one-on-one support to guide them through their kidney health journey.